ARAF and cancer: In the AACR Project GENIE public database cohort v14.1, as depicted in Figure 1A, the ARAF mutation rate is 1.04% in the pan-cancer group (1678/160,965 cases), with pan-lung cancers displaying slightly elevated frequencies of ~1.44% (349/24,175 cases).